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Abstract 
The ATP synthase in human mitochondria is a membrane bound assembly of 29 
proteins of 18 kinds. All but two membrane components are encoded in nuclear genes, 
synthesized on cytoplasmic ribosomes and imported into the matrix of the organelle. 
Here, they are assembled into the complex with ATP6 and ATP8, the products of 
overlapping genes in mitochondrial DNA. Disruption of individual human genes for 
the nuclear encoded subunits in the membrane portion of the enzyme leads to the 
formation of intermediate vestigial ATPase complexes that provide a description of the 
pathway of assembly of the membrane domain. The key intermediate complex consists 
of the F1-c8 complex inhibited by the ATPase inhibitor protein, IF1, and attached to the 
peripheral stalk, with subunits e, f and g associated with the membrane domain of the 
peripheral stalk. This intermediate provides the template for insertion of ATP6 and 
ATP8 which are synthesized on mitochondrial ribosomes. Their association with the 
complex is stabilized by the addition of the 6.8 proteolipid, and the complex is coupled 
to ATP synthesis at this point. A structure of the dimeric yeast Fo membrane domain is 
consistent with this model of assembly. The human 6.8 proteolipid (yeast j-subunit) 
locks ATP6 and ATP8 into the membrane assembly, and the monomeric complexes 
then dimerize via interactions between ATP6 subunits and between 6.8 proteolipids (j-
subunits). The dimers are linked together back-to-face by DAPIT (diabetes associated 
protein in insulin sensitive tissue; yeast subunit k) forming long oligomers along the 
edges of the cristae.  
Significance Statement 
Mitochondria generate the cellular fuel, adenosine triphosphate (ATP) to sustain 
complex life. Production of ATP depends on oxidation of energy rich compounds to 
produce the proton motive force (pmf), a chemical potential difference for protons, 
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across the inner membrane. The pmf drives the ATP synthase, a molecular machine 
with a rotary action, to synthesize ATP. We have shown that the assembly of human 
ATP synthase in the inner organellar membrane involves the formation of a monomeric 
intermediate made from twenty-five nuclear encoded proteins into which the two 
mitochondrially encoded subunits are inserted and then sealed by association of another 
nuclear encoded protein, thereby dimerizing the complex. Association of a final nuclear 
protein oligomerizes the dimers back-to-face along the cristae edges.  
Introduction 
The ATP synthase in human mitochondria provides most cellular ATP under aerobic 
conditions. Energy derived from oxidative metabolism generates a proton-motive force 
(pmf) across the inner membrane of the organelle, and the ATP synthase harnesses the 
pmf to make ATP from ADP and phosphate (1, 2). Human ATP synthase is an assembly 
of 29 subunits of 18 types (including the regulatory protein, IF1) with a combined 
molecular weight of 592 kDa (3). The subunits are organized into membrane extrinsic 
and membrane intrinsic domains, linked by central and peripheral stalks (Fig. 1). 
The protein subunits emanate from two genomes. In humans and other 
vertebrates, ATP6 and ATP8 are encoded in overlapping genes in mitochondrial DNA 
(4) and are translated inside mitochondria. The other subunits, produced from nuclear 
genes, are translated in the cellular cytoplasm, imported into the organelle and 
assembled together with ATP6 and ATP8 to produce the complete ATP synthase. 
Although the assembly of the yeast ATP synthase has been studied extensively (5, 6), 
until recently, relatively little was known about how human ATP synthase is assembled. 
However, gene-editing now permits individual subunits of the human enzyme to be 
removed, and the consequences for assembly can then be examined. Thus, in the 
absence of subunit c an incomplete ATP synthase is formed lacking the c8-ring, ATP6, 
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ATP8, DAPIT and 6.8PL (7). Likewise, removal of either the OSCP or subunit b leads 
to loss of the entire peripheral stalk, plus ATP6, ATP8, and the five supernumerary 
subunits, leaving F1-c8 inhibited by IF1 (8). The mitochondria in human ρ0 cells lack 
organellar DNA, and contain another incomplete ATP synthase, necessarily with no 
ATP6 or ATP8 (7, 9). These incomplete vestigial ATP synthases give insights into the 
pathway of assembly of the complete enzyme. Here, we have investigated the effects 
of the selective removal of supernumerary membrane subunits e, f, g, DAPIT and 6.8PL 
on assembly of human ATP synthase. 
Results 
Human Cells Lacking Supernumerary Subunits. The human genes ATP5I, ATP5J2, 
ATP5L, USMG5 and C14orf2 (SI Appendix, Fig. S2) encoding, respectively, subunits 
e, f, g, DAPIT and 6.8PL of ATP synthase were disrupted in HAP1-WT (wild-type) 
cells (SI Appendix, Tables S1 and S2; Fig. S3). Each of the mutant cells, HAP1-Δe, -
Δf, -Δg, -ΔDAPIT and -Δ6.8PL, did not express the eponymous subunit (Fig. 2). The 
removal of subunits e, f, g or DAPIT had little effect on cellular growth (SI Appendix, 
Fig. S4), except that HAP1-Δe cells reached a similar level of confluence to HAP1-WT 
cells, and then declined. Also, the growth of HAP1-Δg cells was slightly retarded, but 
reached a maximum growth similar to controls. In contrast, the removal of 6.8PL 
retarded cellular growth, but there is no extant explanation. The removal of any one of 
subunits e, f or g had a severe effect on respiration (SI Appendix, Fig. S4), and is similar 
to removing the OSCP or subunit b or c (7, 8). In HAP1-Δe, -Δf or -Δg cells, the lack 
of effect of oligomycin indicated that the vestigial ATP synthase is uncoupled from 
pmf. In HAP1-Δ6.8PL cells, there was evidence of coupled ATP synthase, albeit at 
reduced levels, and also of a residual functional respiratory chain. The HAP1-ΔDAPIT 
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cells retained almost normal levels of coupled ATP synthase and respiration. The 
effects of removal of 6.8PL and DAPIT differ from earlier proposals (10, 11). 
Vestigial ATP Synthases. HAP1 cells lacking any one of subunits e, f, g, DAPIT and 
6.8PL all assemble vestigial ATP synthase complexes (Fig. 3). Each has a full 
complement of the α-, β-, γ-, δ- and ε-subunits forming the F1-domain, and of the 
peripheral stalk subunits OSCP, b, d and F6. The HAP1-Δe, -Δf and -Δg cells, but not 
the HAP1-ΔDAPIT and -Δ6.8PL cells, also lack ATP6 and ATP8. The effects of 
deleting one supernumerary subunit on the absence or presence of another are more 
difficult to discern, but removal of either subunit e or g is accompanied by the loss of 
all other supernumerary subunits, and loss of the 6.8PL accompanies the removal of 
subunit f. 
 The subunit compositions of purified vestigial complexes defined by 
quantitative mass spectrometry (MS) were in agreement with the gel profiles (Fig. 4; 
SI Appendix, Fig. S5; Datasets S1-S10), and the analyses of mitoplasts (SI Appendix, 
Figs. S5 and S6; Datasets S11-S20) were consistent with the following conclusions. 
Removal of subunit e or g was accompanied by loss of all other supernumerary 
subunits, plus ATP6 and ATP8. The peripheral stalk subunits were depleted partially, 
but the rest of the complex was unaffected. The vestigial complex from HAP1-Δf cells 
lacked ATP6, ATP8, DAPIT and 6.8PL, but otherwise had a full complement of 
subunits. In contrast, when DAPIT was removed, all other subunits were retained fully. 
The removal of the 6.8PL led to partial loss of ATP6, ATP8 and DAPIT only. In every 
instance save one, the formation of the vestigial complexes was accompanied by an 
elevation in the relative level of IF1-M1 (7). The exception was the removal of DAPIT 
where the levels of all forms of IF1 were unchanged. In mitoplasts from HAP1-Δe, -Δf, 
-Δg and -Δ6.8PL cells, the relative levels of DAPIT were decreased to a lesser extent 
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than in vestigial complexes, indicating the presence of the free protein unassociated 
with the vestigial ATPase complex (SI Appendix, Fig. S5). Conversely, the similarities 
of changes in the content of other subunits between mitoplasts and vestigial ATP 
synthase complexes, suggests that there is no significant pool of unassembled forms of 
these subunits. 
Oligomeric State of Vestigial ATP Synthases. The oligomeric states of the WT and 
vestigial ATP synthases became less stable with increasing concentration of digitonin 
(Fig. 5). There was no evidence for the persistence in any of the mutant cells either of 
the oligomeric complexes observed in the WT-enzyme, or, with the exception of HAP1-
ΔDAPIT cells (Fig. 5; SI Appendix, Fig. S7), and possibly -Δf cells (Fig. 5A, left panel) 
of the dimeric complex; the dimeric state in HAP1-ΔDAPIT cells was reduced relative 
to WT-cells. In contrast, in all cases, a vestigial monomeric complex was present, 
although in HAP1-Δe, -Δf and -Δg cells, but not in HAP1-Δ6.8PL and HAP1-ΔDAPIT 
cells, its apparent molecular weight is slightly smaller than that of the monomeric WT-
ATP synthase, reflecting their subunit compositions. In HAP1-Δe, -Δf, -Δg and -
Δ6.8PL cells, a complex smaller than the monomeric complexes is probably F1-c8 (s1 
in Fig. 5). In HAP1-WT, -Δf, -ΔDAPIT and -Δ6.8PL, but not -Δe or -Δg cells, there 
were high levels of a series of smaller sub-complexes (s2 in Fig. 5) containing subunit 
b, but not F1-subunits or subunit d. 
Turnover of Subunits. When HAP1, HEK or fibroblast cells were grown in the 
presence of glucose, where the cells are predominantly glycolytic, DAPIT was 
significantly less stable than any of the other subunits of the ATP synthase including 
6.8PL (SI Appendix, Fig. S8; Datasets S21-S24). In contrast, when the cells were grown 
in the presence of galactose, which enforces dependence on oxidative phosphorylation, 
the difference between DAPIT and other subunits was abolished almost entirely. 
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Discussion 
The vestigial ATP synthase complexes characterized here and previously (7, 8) have 
been arranged in an order that describes a branched pathway of assembly of the 
membrane domain of the enzyme (Fig. 6). In one arm, the F1-c8 complex, A, is 
converted to B by addition of the peripheral stalk. Insertion of subunits e and g into B, 
together or singly in either order, produces complex C, and subsequent addition of 
subunit f yields complex E. In the second arm, complex D, consisting of the F1-domain 
plus the peripheral stalk and subunits e, f and g, is converted to E by the addition of the 
c8-ring. In complexes A-E, ATP synthesis is uncoupled from pmf, and the hydrolytic 
activity of their F1-domains appears to be inhibited by IF1. The two arms converge at 
E, a complex of thirteen nuclear encoded subunits plus IF1 each imported individually 
into the mitochondrial matrix before or during assembly. This complex, made of a total 
of twenty-five proteins, provides the template for the insertion of ATP6 and ATP8 
singly, in either order, or together. Both are translated on mitochondrial ribosomes, 
probably close to the matrix surface of the inner membrane. The resulting complex F 
is partially coupled to ATP synthesis (SI Appendix, Fig. S4E), and is somewhat unstable 
as ATP6 and ATP8 are sub-stoichiometric. The addition of 6.8PL stabilizes ATP6 and 
ATP8 in complex G, producing an active enzyme coupled to ATP synthesis with no 
accompanying increase of IF1 (Fig. 4; SI Appendix, Fig. S4D).  
 In mitochondrial membranes, the ATP synthase is dimerized via 
interactions in the membrane domain, and the dimers form extensive front-to-back rows 
along the edges of the cristae (12–14). Dimerization of the yeast enzyme depends on 
the presence of subunits e and g (15), and they associate sequentially with a monomeric 
complex leading to an assembly ready to dimerize (16). In a structure of the dimeric Fo 
membrane domain of the yeast enzyme (17), neither of these subunits makes contacts 
	 8	
across the monomer-monomer interface, which involves mainly contacts between the 
two subunits j and the two ATP6 subunits. However, the requirement for the presence 
of e and g for dimerization to occur is explained by the assembly pathway for the human 
enzyme, as both subunits have to be present in the growing complex before ATP6 (and 
ATP8) can be inserted, and subsequently stabilized by the association of 6.8PL (Fig. 
6). Two important conclusions can now be drawn. First, the 6.8PL and yeast subunit j 
are almost certainly functional orthologs, and relationships between their sequence and 
positions of trans-membrane α-helices support this view (SI Appendix, Fig. S9A). 
Second, dimerization most likely follows the insertion of ATP6 and ATP8 and 
association of the 6.8 PL. The native gel analyses (Fig. 5) and those published 
elsewhere (7, 9) are in accord with this suggestion. The final step in the assembly 
pathway, the addition of DAPIT, produces the fully assembled enzyme, complex H 
(Fig. 6). DAPIT is the most peripheral of the membrane subunits, and unless it is 
stabilized by the addition of exogenous phospholipids, mild detergents other than 
digitonin remove it from the purified complex (18, 19). The most likely role of DAPIT 
is to form links between dimers of ATP synthase to produce the rows of dimeric 
complexes along the “edges” of the cristae (12–14). In the model of the yeast dimeric 
Fo-domain, the incomplete structure of subunit k is associated with subunit ATP6 and 
is distal from the monomer-monomer interface (Fig. 7). In this position, it is well placed 
to make contacts between dimers in the oligomeric rows of dimers in mitochondrial 
inner membranes. It is likely that DAPIT and yeast subunit k are orthologs (SI 
Appendix, Fig. S9B). Therefore, the S. cerevisiae and human ATP synthases have the 
same complement of subunits (Table S3). The relative stability of DAPIT under 
conditions of oxidative metabolism may reflect its role in dimer-dimer interactions 
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during the re-modeling of mitochondria associated with fission and fusion of the 
dynamic network of mitochondria in cells. 
 In S. cerevisiae, assembly factors ATP11 and ATP12 participate in the 
formation of the F1-domain (20). Another assembly factor FMC1 (formation of 
complex V assembly factor 1) helps at elevated temperatures, and its loss can be 
compensated by overexpression of ATP12 (21). The human orthologs are ATPAF1, 
ATPAF2 and C7orf55 (22, 23), but since their role is in the formation of the F1-domain, 
it is unsurprising that they were not significantly associated with complexes A-G (Fig. 
6; SI Appendix, Fig. S5 and Datasets S1-S20). Another assembly factor INAC (inner 
membrane assembly complex), made of components of 22 and 17 kDa, is required for 
the assembly of the yeast peripheral stalk (6, 24). However, no human orthologs have 
been recognized from sequences, and how the human peripheral stalk is assembled, 
before being added to the F1-domain or to complex A (Fig. 6), remains unclear. A 
subcomplex of subunits b, e and g has been proposed to be an assembly intermediate 
(25), and it may be among the s2 subcomplexes (Fig. 5B). It is worth noting that the 
extrinsic membrane domain of the bovine peripheral stalk assembles from its four 
constituent proteins in vitro, and that the assembled complex will then associate with 
the bovine F1-ATPase spontaneously to produce an F1-peripheral stalk complex 
(lacking the membrane domain); both events proceed without the aid of exogenous 
protein factors (26). The compositions of complexes B and D (Fig. 6) show that the 
peripheral stalk can be added to either the separate F1-domain or the F1-domain in the 
F1-c8 complex, and a similar conclusion has been reached with the yeast ATP synthase 
(6). The yeast c10-ring probably assembles separate from the F1-domain or the F1-
peripheral stalk complex, and subsequently the F1-c10 complex or the fully assembled 
enzyme forms (5, 6). A similar process may operate in human mitochondria, but the 
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mechanisms of assembly of the c8-ring and the S. cerevisiae c10-ring necessarily differ, 
as the human c-subunit is encoded by three nuclear genes and is imported into the 
organelle (27, 28), whereas the yeast c-protein is a mitochondrial gene product made in 
the mitochondrial matrix (29). Additionally, yeast ATP6 is made as a precursor with an 
N-terminal extension, which is removed by the inner membrane protease ATP23 during 
assembly (30, 31); human ATP6 has no precursor. Also, yeast ATP6 and ATP8 are 
associated first, with either the peripheral stalk or the F1-peripheral stalk subcomplex, 
together with assembly factors ATP23, ATP10 and INAC, and then associated with the 
c10-ring to form the complete complex (5, 6). This pathway differs from the one 
proposed here for the human enzyme as ATP6 and ATP8 are incorporated after the F1-
peripheral stalk-c8 complex has formed, and then this complex is stabilized by the 
6.8PL (Fig. 6, complexes F and G). 
 TMEM70 is a membrane protein that has been suggested to participate 
in the assembly of the membrane domain of human ATP synthase (32, 33), but neither 
this protein nor any other plausible assembly protein was increased in their association 
with vestigial complexes A-G (Fig. 6; SI Appendix, Fig. S5 and Datasets S1-S20). 
However, it seems likely that assembly proteins do participate in this pathway, and 
other methods such as complexomics (34, 35) may be more successful in identifying 
candidates. 
Materials and Methods 
Human genes ATP5I, ATP5J2 and ATP5L were disrupted in HAP1 cells by CRISPR-
Cas9 with pairs of guide RNAs (SI Appendix, Table S1) as described before (7), leading 
to clonal cells HAP1-Δe, -Δf and -Δg, respectively. Clonal cells HAP1-Δ6.8PL 
(C14orf2) and HAP1-ΔDAPIT (USMG5) were purchased from Horizon Discovery, 
Cambridge, U. K. Cell proliferation was monitored with an Incucyte HD instrument 
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(Essen Bioscience), and the oxygen consumption of cells was measured in a Seahorse 
XFe24 (Agilent Technologies). The oligomeric state of ATP synthase and vestigial 
complexes was examined by BN-PAGE and Western blotting. ATP synthase and 
vestigial complexes were immuno-purified from mitoplasts, analyzed by SDS-PAGE, 
stained with Coomassie blue and bands analyzed by MS. Proteins were subject to stable 
isotope labelling by amino acids in cell culture (SILAC), and quantitated by MS. For 
details, see SI Appendix. 
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Figure Legends 
 
Fig. 1. Organization of subunits in monomeric ATP synthase in mammalian 
mitochondria. Black horizontal lines represent the inner membrane; IMS, inter-
membrane space. The peripheral stalk (subunits OSCP, F6, b and d) is on the right. 
Subunit b has two N-terminal transmembrane α-helices interacting directly or indirectly 
with subunits e, f, g, DAPIT and 6.8PL, which have no known roles in synthesis or 
hydrolysis of ATP. Each has a single predicted transmembrane α-helix (SI Appendix, 
Fig. S1). The membrane domain of subunit b is associated with mitochondrially 
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encoded subunits ATP6 and ATP8. The N-terminal region of ATP8 has a single 
transmembrane α-helix and its C-terminal region extends into the peripheral stalk; 
ATP8 and subunit b keep ATP6 in contact with the c8-ring. The pmf drives the rotation 
of this ring and the attached central stalk (subunits γ, δ and ε) by the translocation of 
protons through the interface between the c8-ring and ATP6. The rotation of the central 
stalk carries energy into the three catalytic sites in the F1 domain (subunit composition 
α3β3γδε); an α-subunit has been removed to expose the central γ-subunit. 
 
 
 
Fig. 2. Absence from clonal HAP1 cells of individual supernumerary subunits of ATP 
synthase. Mitoplasts were prepared from HAP1-wild type (WT) cells and HAP1-Δe, -
Δf, -Δg, -ΔDAPIT and -Δ6.8PL clonal cells. In the HAP1-Δf cells, f1 and f2 denote 
isoforms of subunit f. The mitoplasts were extracted with dodecylmaltoside. The 
extracts were fractionated by SDS-PAGE and Western blotted with antibodies against 
the corresponding subunits. Citrate synthase (cs) provided loading controls. 
	 17	
 
Fig. 3. Subunit compositions of vestigial ATP synthase complexes produced by 
removal of individual supernumerary membrane subunits. The complexes were 
immuno-purified from mitoplasts derived from HAP1-WT (wild type), -Δe, -Δf, -Δg, -
ΔDAPIT and -Δ6.8PL cells, fractionated by SDS-PAGE and stained with Coomassie 
blue. The positions of subunits are indicated. IgG, immunoglobulin. 
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Fig. 4. Effects of removal of individual supernumerary membrane subunits on human 
ATP synthase. (A)-(E), relative abundances of subunits, and forms M1, M2 and M3 of 
IF1, in immuno-purified ATP synthase and vestigial complexes, from clonal cells. (A), 
HAP1-Δe; (B), HAP1-Δf; (C), HAP1-Δg; (D), HAP1-ΔDAPIT; and (E), HAP1-
Δ6.8PL. The histograms, derived from SI Appendix, Fig. S5 and Datasets S1-S10, are 
the median values of both relative abundance ratios determined for proteins found in 
complementary SILAC experiments. Error bars show the range of the two values. IF1-
M1, -M2 and -M3 are different mature forms of IF1, and f-1 and f-2 are isoforms of 
subunit f (Swissprot P56134). Similar experiments conducted on mitoplasts are 
presented in SI Appendix Fig. S6.  
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Fig. 5. Oligomeric states of ATP synthase and vestigial forms in HAP1 cells. ATP 
synthase and vestigial complexes were extracted at various digitonin/protein (g/g) 
ratios indicated above the lanes, from mitoplasts of HAP1-WT, HAP1-Δe, HAP1-Δf, 
HAP1-Δg, HAP1-ΔDAPIT, and HAP1-Δ6.8PL cells. Extracts were fractionated by 
BN-PAGE, and complexes were revealed by Western blotting with antibodies against 
various subunits of ATP synthase: (A), β-subunit; (B), b-subunit; (C), g-subunit; (D), d-
subunit. cs, citrate synthase as loading control. The positions of the complexes are 
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indicated on the left; o, oligomers; d, dimers; m, monomers; s1, F1-c8 sub-complexes; 
s2, sub-complexes containing subunits b, e and g. 
 
 
 
Fig. 6. Pathway of assembly of the membrane domain of human ATP synthase. Panels 
A-D and F and G, intermediate vestigial complexes, and subunit compositions 
characterized from mitochondria of clonal cells: A, HAP1-Δb or -ΔOSCP; B, HAP1-
Δe or -Δg; C, HAP1-Δf; D, HAP1-Δc; F, HAP1-Δ6.8PL; G, HAP1-ΔDAPIT. E, 
vestigial complex from the mitochondria of ρ0 cells. The horizontal black lines denote 
the boundaries of the inner mitochondrial membrane. Panel H, the complete monomeric 
ATP synthase. 
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Fig. 7. Structure of the dimeric Fo domain the ATP synthase from S. cerevisiae (17). 
The c10-ring is grey and other subunits are colored and identified on the structures. In 
(A) and (B), the two associated monomers are viewed from the matrix and from the 
inter-membrane space, respectively. The interface between monomers is formed mainly 
by the two ATP6 (or a) subunits and by the two j-subunits. Here, it is proposed that 
subunit j and the human 6.8PL (labelled 6.8) are orthologs. It is also proposed that 
subunit k is the ortholog of human DAPIT and that these subunits assist in the formation 
of oligomeric structures consisting of rows of dimers along the edges of the 
mitochondrial cristae. 
	 1	
SI Appendix for: 
Assembly of the membrane domain of ATP synthase in 
human mitochondria 
Jiuya He, Holly C. Ford, Joe Carroll, Corsten Douglas, Evvia Gonzales, Shujing 
Ding, Ian M. Fearnley and John E. Walker 
Medical Research Council Mitochondrial Biology Unit, University of Cambridge, 
Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, United Kingdom 
Materials and Methods 
Gene disruptions. The genes for the e, f, g, DAPIT and 6.8PL subunits were 
disrupted individually in human HAP1-WT cells by CRISPR-Cas9 technology (1). 
The structures of the genes are shown in SI Appendix, Fig. S2. HAP1 cells have a 
haploid karyotype, except for the presence of a fragment of chromosome 15 in 
chromosome 19 and a reciprocal translocation between chromosomes 9 and 22. None 
of these features affects the genes in question, as ATP5I, ATP5J2, ATP5L, USMG5 
and C14orf2 are on chromosomes 4, 7, 11, 10 and 14, respectively. For ATP5I, 
ATP5J2 and ATP5L, pairs of gRNAs characteristic of exon I and intron A were 
selected (SI Appendix, Table S1). Each pair was introduced independently into HAP1-
WT cells, and screening of clones from single cells for the absence of subunit e, f or g 
led to the identification of HAP1-Δe, -Δf and -Δg cells. The deletions in HAP1-Δe, -
Δf and -Δg cells were 51, 83 and 104 bp, respectively, (SI Appendix, Table S2 and 
Fig. S3, parts A, B and C). Each deletion had arisen from two gRNAs and non-
homologous end-joining of the deleted genomic DNA. All three deletions included 
the translational start codon and upstream sequence, and extended across the junction 
between exon I and intron A, into intron A. The gene disruptions of USMG5 and 
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C14orf2 in HAP1-ΔDAPIT and HAP1-Δ6.8PL cells, had been introduced with single 
gRNA molecules by Horizon Discovery, Cambridge, U. K. The 43 bp deletion in the 
former extends from the 3’ end of intron B into exon III, and does not include the 
translational start codon, which is in exon II, and the impact on transcription of the 5’-
coding region is not known (SI Appendix, Fig. S3D). The 10 bp deletion in the HAP1-
Δ6.8PL cells introduces a frame-shift after codon 17 with the effects of conserving 
codon 18, mutating codons 19-22 and introducing a termination codon at codon 23 (SI 
Appendix, Fig. S3E).  
Cell Culture. HAP1-WT (Horizon Discovery) and clonal cells were cultured in 
Iscove’s modified Dulbecco’s medium under standard conditions (2). Cell 
proliferation was monitored with an Incucyte HD instrument (Essen Bioscience) and 
oxygen consumption rate (OCR) was measured in a Seahorse XFe24 analyzer 
(Agilent Technologies), as described before (2). OCR was normalized to cell number 
by the sulforhodamine B assay (3). Stable isotope labelling of proteins with amino 
acids in cell culture (SILAC) of HAP1-WT and gene disrupted clonal cells was 
carried out as described before (2). Human embyonic kidney cells (HEK293) and 
immortalized human skin fibroblast cells (a gift from Dr. E. Fernandez-Vizarra, 
MRC-Mitochondrial Biology Unit, Cambridge, U. K.) were cultured at 37°C under 
5% CO2 in high glucose (4.5 g/l) Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with fetal bovine serum (10% v/v), penicillin (100 U/ml) and 
streptomycin (100 µg/ml). To assess the effect on protein turnover of substituting 
glucose for galactose in cell culture media, skin fibroblasts were cultured in DMEM 
lacking glucose, pyruvate and all amino acids (Dundee Cell Products Ltd, Dundee, U. 
K.), supplemented for SILAC, and in addition with glucose (25 mM) or galactose (25 
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mM), pyruvate (1 mM) and all other amino acids at standard concentrations for 
DMEM. 
General methods. Cell protein concentrations were determined by either the 
bicinchoninic acid assay (Thermo Fisher Scientific) or the detergent compatible 
protein assay (BioRad). Mitoplasts were prepared from cells with digitonin, as 
described before (2, 4). Extracts of mitoplasts made with dodecylmaltoside (DDM; 
1%, w/v) were fractionated by SDS-PAGE, and subunits of ATP synthase and citrate 
synthase were detected by Western blotting. The oligomeric states of ATP synthase 
and vestigial complexes in digitonin extracts of mitoplasts were examined by BN-
PAGE and Western blotting. Samples of mitoplasts were re-suspended to ca. 5 mg/ml 
in NativePAGE sample buffer (Thermo Fisher Scientific) containing digitonin (6-10 
g/g protein), kept at 4°C for 15 min, and then centrifuged (10,500 x g, 20 min, 4°C). 
The supernatants were treated with benzonase (Merck Millipore) at room temperature, 
centrifuged again, and soluble complexes fractionated by BN-PAGE at 4°C in 3-12% 
acrylamide gradient Bis-Tris gels (Thermo Fisher Scientific) according to the 
manufacturer’s instructions for Western blotting. The origins of the antibodies have 
been described before (5), or are given in SI Appendix Table S4. ATP synthase was 
purified from digitonin solubilized mitoplasts with an immuno-capture resin (Abcam) 
as described before (2). For the SDS-PAGE profiles (Fig. 3), digitonin in the bead 
wash solution was replaced by DDM (0.05% w/v). Samples for mass spectrometric 
analysis were reduced and alkylated in gel sample buffer, fractionated by SDS-PAGE 
and stained with Coomassie blue R250 dye (6). Bands were excised and proteins 
digested in-gel with trypsin (7). The extracted peptide mixtures were analyzed in a 
MALDI-TOF-TOF instrument (model 4800, AB-Sciex) and the proteins were 
identified from the tandem-MS data (8).  
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Protein quantitation. Relative quantitation of proteins was derived from mass 
spectrometric data from SILAC samples (9). LC-MS-MS of tryptic peptide mixtures 
was performed on a Proxeon EASY-nLC system coupled directly to a Q-Exactive 
Orbitrap mass spectrometer (Thermo Fisher Scientific). Heavy and light peptide mass 
data were analyzed with MaxQuant version 1.5.8.3, and the integrated Andromeda 
search engine (10, 11) employing a Swiss-Prot human protein database (January 
2017) modified to include mature forms of ATPIF1, denoted as IF1-M1, -M2 and -
M3, with N-terminal residues Phe-25, Gly-26 and Ser-27, respectively (12, 13). 
Search parameters were: MS tolerance 4.5 p.p.m.; MS/MS tolerance 20 p.p.m.; 
Trypsin/P with two missed cleavages; Cys-carbamidomethyl fixed; oxidation (Met) 
and acetyl (protein N-term) variable; Arg-10 and Lys-8. The MaxQuant output was 
managed further with Perseus (14). Protein ratios for ATPIF1 were calculated 
manually using data specific for the unique N-terminal peptides of the various mature 
forms of ATPIF1, located in the MaxQuant evidence file, and represent the median of 
the assigned specific peptide ratios, where MaxQuant ISO-MSMS peptide values 
were used only if fewer than three MULTI-MSMS peptide ratios were obtained. The 
basis of quantitative experiments using SILAC has been described previously (15). 
Analysis of turnover rates of ATP synthase subunits in the native enzyme. Cells 
were cultured for 24 h in light SILAC medium, transferred into heavy SILAC 
medium for varying periods of time (1-24 h), washed with PBS and then harvested. 
Mitochondrial inner membranes were prepared from the cells (6) and membrane 
protein complexes extracted with DDM (3 g/g protein) and analyzed by BN-PAGE. 
The proteins in the gels were stained with Coomassie blue R250. Bands 
corresponding to monomeric ATP synthase were excised and the proteins were 
digested in-gel with trypsin. The peptides were extracted and relative quantitation of 
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proteins was performed by quantitative mass spectrometry and MaxQuant data 
processing as described above. Heavy/light protein ratios were transformed to give 
the proportion of light labelled protein, and were expressed as the percentage of light 
labelled protein remaining at each time point. Because the cells proliferate, the 
quantity of heavy labelled proteins increases over time. Therefore, the absolute rates 
of protein turnover were not determined, but the values represent the relative 
differences in equilibrium state established by synthesis and degradation of proteins. 
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Results 
 
Fig. S1. Predicted structures of supernumerary subunits of human ATP synthase. (A-
E), secondary structures of mature subunits e, f-1, g, DAPIT and 6.8PL, respectively, 
predicted with Jpred 4 (16) and PSIPRED v3.3 (17). H and E below the sequences 
denote residues predicted to form α-helices or β-sheets, respectively. In subunits e, f-
1, DAPIT and 6.8PL, yellow boxed regions are transmembrane α-helices predicted 
with TMHMM (18). In subunit g, a transmembrane α-helix was predicted by TMpred 
(https://www.ch.embnet.org/software/TMPRED_form.html), but not TMHMM. In 
subunits f and g, the N-terminal alanine residues are acetylated, and internal 
methionine residues, denoted as M, are potential secondary translation initiation sites. 
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Fig. S2. Structures of the human genes for five supernumerary subunits of ATP 
synthase. ATP5I, ATP5J2, ATP5L, USMG5 and C14orf2 encode the e, f, g, DAPIT 
and 6.8PL subunits, respectively. Black and unfilled boxes represent, respectively, 
protein coding and non-coding regions in exons. Exons are labelled with roman 
numerals. Introns are depicted as intervening continuous lines. The sizes of introns 
and coding regions of exons are given in base pairs (bp). The scale bar in ATP5I 
represents 100 bp, and those in ATP5J2, ATP5L, USMG5 and C14orf2 correspond to 
500 bp. The exon-intron information was obtained from http://www.ensembl.org. The 
structures of ATP5I, ATP5J2, ATP5L, USMG5 and C14orf2 correspond to reference 
sequences NM_007100, NM_004889, NM_006476, NM_001206426 and 
NM_004894, respectively. A second isoform of subunit f is produced from an 
alternative splice variant of ATP5J2, at the exon I-intron A boundary, producing a 
transcript 18 bp shorter at the 3’ end of exon I (RefSeq NM_001003713). Images 
were drawn with the Exon-Intron graphic maker (http://wormweb.org/exonintron). 
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Table S1. Target sites for gRNA molecules employed in the disruption of human 
genes ATP5I, ATP5J2 and ATP5L, encoding subunits e, f and g, respectively, of 
human ATP synthase 
gRNA Sequence 
ATP5I-1 GTGCTTCCGGTGCGGAGGTC 
ATP5I-2 TCCGCTCATCAAGGTGATCC 
ATP5J2-1  TCGCGCGGTCCGGCACAGCG* 
ATP5J2-2 GTAAGGCTGTTTGGACTCCG 
ATP5L-1  GCGGTTCGGGGCGACGGACT* 
ATP5L-2 AGCGCGATGTGAGACCGCCG 
*anti-sense sequence used for gRNA 
 
Table S2. Primers employed in the amplification by PCR of regions targeted by 
gRNAs in ATP5I, ATP5J2 and ATP5L. 
Primers Sequence 
ATP5I-Forward CCGCTCTCTCGCCGCT 
ATP5I-Reverse CCAGAGCACTGGGCGG 
ATP5J2-Forward  CTGCAGGACCCTCGGATTTT 
ATP5J2-Reverse TTCACCCTCCACGCCTAAC 
ATP5L-Forward GGTTTTCCGGACCTCTACGA 
ATP5L-Reverse ATCTGCAGGTCAGACGAGTG 
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Fig. S3. Disruption of genes for supernumerary subunits of ATP synthase. CRISPR 
directed deletions were introduced into HAP1 cells in the sequences of the following 
genes: (A), ATP5I; (B), ATP5J2; (C), ATP5L; (D), USMG5; and (E), C14orf2. The 
corresponding clonal cells HAP1-Δe, -Δf, -Δg, -ΔDAPIT and -Δ6.8PL were isolated 
subsequently. Carets indicate the PAM (protospacer adjacent motif) sequences for 
each guide RNA, and solid lines the target sequences for guide RNAs. In (A)-(C), the 
wild-type (WT) sequences are parts of exon I and intron A (grey box), aligned with 
the corresponding deleted sequences. The arrows indicate the start codons in exon I. 
In (D), the WT DNA sequence in part of intron B (grey box) and exon III, is aligned 
with the corresponding mutated sequence. In (E), the upper panel is an internal DNA 
sequence in exon II of C14orf2 aligned with the corresponding deleted sequence, and 
the lower panel shows the impact of the deletion on the sequence of the 6.8PL 
subunit. In (A)-(E), the deleted regions are denoted by dashed lines, and in (E), 
asterisks indicate mutations introduced by the process of non-homologous repair. 
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Fig. S4. Impact of disruption of genes for supernumerary subunits e, f, g, DAPIT and 
6.8PL on growth and respiration of HAP1 cells. (A-E), growth rates (left hand side) 
and cellular oxygen consumption rates (OCR) (right hand side) of HAP1-WT cells 
(●) and HAP1 cells with disrupted genes for subunits (■). A, Δe; B, Δf; C, Δg; D, 
ΔDAPIT; E, Δ6.8PL. Growth rates were measured by seeding 105 cells into each well 
of a 6-well plate, and by monitoring their confluence over time. Where necessary, 
initial confluences were adjusted to similar levels for comparison. The data points are 
the mean values ±SD (n=2-3 wells). OCR was measured before and after sequential 
additions of oligomycin (Oligo), carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP), and a mixture of rotenone and antimycin 
A (Rot/AA). Data represent the mean ±SEM (n=6-10 wells). 
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Fig. S5. Effects on protein relative abundance of the individual deletion of 
supernumerary subunits of the human ATP synthase complex in HAP1 cells. (A)-(E), 
relative abundances of proteins in immuno-purified ATP synthase and vestigial 
complexes (left-hand panels), and in mitoplasts (right-hand panels). (A), HAP1-Δe; 
(B), HAP1-Δf; (C), HAP1-Δg; (D), HAP1-ΔDAPIT; and (E), HAP1-Δ6.8PL. Samples 
were prepared from a 1:1 mixture of HAP1-Δ cells with HAP1-WT cells that were 
differentially SILAC-labelled, and the experiments were performed twice, using 
reciprocal SILAC labelling orientations. The ratios from each experiment are plotted 
on the horizontal and vertical axes, respectively, of a scatter plot as the log base 2 
value.  ●, ATP synthase subunits and forms of the inhibitor protein, IF1; ●, assembly 
factors ATPAF1, ATPAF2, C7orf55 and TMEM70; ●, all other proteins. Protein 
ratios are listed in SI Appendix, Datasets S1 to S20. 
 
 
 
 
	 16	
 
 
Fig. S6. Effects of removal of individual supernumerary membrane subunits on 
human ATP synthase. (A)-(E), relative abundances of ATP synthase subunits, and 
forms M1, M2 and M3 of IF1, in mitoplasts from clonal cells. (A), HAP1-Δe; (B), 
HAP1-Δf; (C), HAP1-Δg; (D), HAP1-DAPIT; and (E), HAP1-6.8PL. The histograms, 
derived from SI Appendix, Fig. S5 and Datasets S11-S20, are the median values of 
both relative abundance ratios determined for proteins found in complementary 
SILAC experiments. Error bars show the range of the two values. IF1-M1, -M2 and -
M3 are different mature forms of IF1, and f-1 and f-2 are isoforms of subunit f 
(Swissprot P56134). Except for mitoplasts from HAP1-Δ6.8PL cells, where the 
values for the 6.8PL and ATP8 are from a single peptide ratio for the control heavy 
isotope/Δ6.8PL light isotope experiment, the protein ratio is derived from a minimum 
of two peptide ratios from each complementary SILAC experiment. In the HAP1-Δf 
and -Δ6.8PL samples, the relative abundance of the c-subunit was not determined. 
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Fig. S7. Effect of deletion of DAPIT on the assembly of ATP synthase. Mitoplasts 
were prepared from HAP1-wild type cells (WT) and HAP1-ΔDAPIT cells at passage 
9 (left hand panels) or passage 24 (right hand panels), solubilized with digitonin (dig), 
and protein complexes were fractionated by BN-PAGE and transferred 
electrophoretically to a polyvinylidene difluoride membrane. ATP synthase 
complexes were detected with an antibody against the α-subunit. o, oligomer; d, 
dimer; m, monomer. Citrate synthase (CS) was employed as a loading control. 
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Fig. S8. Turnover of assembled subunits of ATP synthase. Experiments were 
performed in (A), HAP1 cells; (B), HEK cells; (C) and (D), fibroblasts. Cells were 
grown initially in ‘light’ SILAC medium and then from time zero in ‘heavy’ SILAC 
medium. In (A), (B) and (C), the culture medium contained 25 mM glucose; in (D), 
the glucose was replaced by 25 mM galactose. After various periods of growth, cells 
were harvested, and mitochondrial membranes were prepared. Membrane proteins 
were solubilized with DDM (3 g/g), and fractionated by BN-PAGE. The bands 
containing ATP synthase were excised, the proteins digested with trypsin, and the 
peptides were analysed by quantitative mass spectrometry. The heavy/light protein 
ratios produced by MaxQuant were converted to the residual percentage of light-
labelled protein. (●), α-subunit; (◼), β-subunit; (▲), γ-subunit; (▼), δ-subunit; (◆), ε-
subunit; (●), b-subunit; (◼), d-subunit; (▲), F6-subunit; (▼), OSCP; (●), e-subunit; 
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(◼), f-subunit; (▲), g-subunit; (▼), 6.8PL; (◆), DAPIT; (●), ATP6; (◼), ATP8. In 
panel (A), no data are shown for the ε-subunit, and in panels (B), (C) and (D), for 
ATP6. In panel (C), single time points represent subunits ε and 6.8PL, and in (D), 
similarly for 6.8PL. The data are taken from SI Appendix, Datasets S21 to S24. In (A) 
to (D), no data were obtained for subunit c.  
 
 
 
 
Fig. S9. Comparison of sequences of 6.8PL and DAPIT subunits of human ATP 
synthase with proposed yeast orthologs. (A), 6.8PL and yeast subunit j (ATP18); (B), 
DAPIT and yeast subunit k (ATP19). Asterisks denote identities and colons and full 
stops conserved residues. The alignments were produced with CLUSTAL. The blue 
regions denote transmembrane α-helices predicted with Jpred 4 (16) and TMHMM 
(18) in the human proteins and observed in the structures of the yeast proteins (19). 
 
 
 
 
 
 
 
 
	 20	
 
 
Table S3. Equivalent genes and orthologous subunits in human and yeast ATP synthases  
Human  S. cerevisiae 
Gene Subunit  Gene Subunit * 
ATP5A1 alpha  ATP1 alpha 
ATP5B beta  ATP2 beta 
ATP5C1 gamma  ATP3 gamma 
ATP5D delta  ATP16 delta 
ATP5E epsilon  ATP15 epsilon 
ATP5F1 Fo complex B1 or b  ATP4 4 or b 
ATP5G1 Fo complex C1†  ATP9 or OLI1 9 or c 
ATP5G2 Fo complex C2 †  - - 
ATP5G3 Fo complex C3 †  - - 
ATP5H d  ATP7 d 
ATP5I e  ATP21 or TIM11 e 
ATP5J coupling factor 6 or F6  ATP14 h 
ATP5J2 f  ATP17 f 
ATP5L g  ATP20 g 
ATP5O O or OSCP  ATP5 5 or OSCP 
MT-ATP6 a or ATP6  ATP6 a or ATP6 
MT-ATP8 protein 8, ATP8 or A6L  ATP8 8 or Aap1 
C14orf2 6.8 kDa mitochondrial proteolipid  ATP18 i or j 
USMG5 Diabetes-associated protein in 
insulin-sensitive tissues 
 ATP19 k 
* Subunit l (20) was not found in the structure of Fo from S. cerevisiae (19). 
†
 C1, C2 and C3 are identical subunits encoded in three different genes. 
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Table S4. Sources of Antibodies 
Protein Source Antibody 
ATP synthase α Proteintech 14676-1-AP 
ATP synthase γ Sigma SAB2700096 
ATP synthase e Sigma HPA035010 
ATP synthase f Santa Cruz Biotechnology sc-241862 
ATP synthase DAPIT Proteintech  17716-1-AP  
ATP synthase 6.8PL Sigma HPA058978 
 
 
